Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine vs Norepinephrine/Vasopressin in Septic Shock
NCT04302584Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2018
- Primary completion
- Jan 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, single-blind trial of vasopressin in septic shock (2 arms), sponsored by Ain Shams University. Primary endpoints: Lactate Level at 48 hours and Central Venous Oxygen Saturation at 48 hours. Started Jan 2018; status: completed.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04302584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04302584.